A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer

Walburga Engel-Riedel; Jamie Lowe; Paulette Mattson; J. Richard Trout; Richard D. Huhn; Michele Gargano; Myra L. Patchen; Richard Walsh; My My Trinh; Mariève Dupuis; Folker Schneller

doi:10.1186/s40425-018-0324-z

A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer

Journal for ImmunoTherapy of Cancer ◽

10.1186/s40425-018-0324-z ◽

2018 ◽

Vol 6 (1) ◽

Cited By ~ 2

Author(s):

Walburga Engel-Riedel ◽

Jamie Lowe ◽

Paulette Mattson ◽

J. Richard Trout ◽

Richard D. Huhn ◽

...

Keyword(s):

Lung Cancer ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Small Cell ◽

Line Treatment ◽

Efficacy And Safety ◽

Small Cell Lung ◽

First Line ◽

Randomized Controlled ◽

First Line Treatment

Download Full-text

Randomized controlled trial of lobaplatin plus etoposide vs. cisplatin plus etoposide as first‑line therapy in patients with extensive‑stage small cell lung cancer

Oncology Letters ◽

10.3892/ol.2019.10125 ◽

2019 ◽

Cited By ~ 1

Author(s):

Ying Cheng ◽

Yun Fan ◽

Xiaoqing Liu ◽

Yunpeng Liu ◽

Jiwei Liu ◽

...

Keyword(s):

Lung Cancer ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Randomized Controlled ◽

First Line Therapy ◽

Line Therapy ◽

Extensive Stage

Download Full-text

1318 A randomized controlled trial of recombinant human endostatin combined with single-agent gemcitabine in the first-line treatment of the elderly patients with advanced non-small cell lung cancer

European Journal of Cancer ◽

10.1016/s0959-8049(16)30561-5 ◽

2015 ◽

Vol 51 ◽

pp. S193

Author(s):

Q. Chen ◽

Q. Shi ◽

Q. Xie ◽

S. Xiao

Keyword(s):

Controlled Trial ◽

Single Agent ◽

The Elderly ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Recombinant Human Endostatin ◽

Randomized Controlled ◽

First Line Treatment

Download Full-text

Efficacy and safety of PF-00299804 (PF299), an oral, irreversible, pan-human epidermal growth factor receptor (pan-HER) tyrosine kinase inhibitor (TKI), as first-line treatment (tx) of selected patients (pts) with advanced (adv) non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7537 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7537-7537 ◽

Cited By ~ 7

Author(s):

T. Mok ◽

D. R. Spigel ◽

K. Park ◽

M. A. Socinski ◽

S. Y. Tung ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Line Treatment ◽

Efficacy And Safety ◽

Small Cell Lung ◽

First Line ◽

Epidermal Growth ◽

First Line Treatment

Download Full-text

The efficacy and safety of bevacizumab in addition to platinum‑based chemotherapy for the first‑line treatment of patients with advanced nonsquamous non‑small‑cell lung cancer: Final results of AVALANCHE, an observational cohort study

Oncology Letters ◽

10.3892/ol.2018.9766 ◽

2018 ◽

Cited By ~ 1

Author(s):

Edina Tolnay ◽

�ron Ghimessy ◽

Erzs�bet Juh�sz ◽

Zsuzsanna Sztancsik ◽

Gy�rgy Losonczy ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell ◽

Observational Cohort Study ◽

Line Treatment ◽

Efficacy And Safety ◽

Small Cell Lung ◽

First Line ◽

Platinum Based Chemotherapy ◽

Observational Cohort ◽

First Line Treatment

Download Full-text

Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2014.07.007 ◽

2014 ◽

Vol 85 (3) ◽

pp. 401-407 ◽

Cited By ~ 10

Author(s):

Yi-Long Wu ◽

Shun Lu ◽

Ying Cheng ◽

Caicun Zhou ◽

Mengzhao Wang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Chinese Patients ◽

Line Treatment ◽

Efficacy And Safety ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Paclitaxel plus platinum or gemcitabine plus platinum in first-line treatment of advanced non-small-cell lung cancer: results from 6 randomized controlled trials

International Journal of Clinical Oncology ◽

10.1007/s10147-012-0502-9 ◽

2012 ◽

Vol 18 (6) ◽

pp. 1005-1013 ◽

Cited By ~ 2

Author(s):

Jingwei Jiang ◽

Xiaohua Liang ◽

Xinli Zhou ◽

Ruofan Huang ◽

Zhaohui Chu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Small Cell ◽

Controlled Trials ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Randomized Controlled ◽

First Line Treatment

Download Full-text

A multi-center, randomized, double-blind, parallel, two-group phase III trial on the efficacy and safety of QL1101 or bevacizumab in combination with paclitaxel and carboplatin in first-line treatment of non-squamous non-small cell lung cancer

Annals of Oncology ◽

10.1093/annonc/mdy442 ◽

2018 ◽

Vol 29 ◽

pp. ix121 ◽

Cited By ~ 1

Author(s):

B. Han ◽

K. Li ◽

T. Chu ◽

M. Bi ◽

H. Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

Small Cell Lung ◽

First Line ◽

Double Blind ◽

Phase Iii Trial ◽

First Line Treatment

Download Full-text

Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-012-1833-y ◽

2012 ◽

Vol 69 (5) ◽

pp. 1265-1275 ◽

Cited By ~ 7

Author(s):

Yong Yu ◽

Xun Xu ◽

Ziyan Du ◽

Minhua Shi

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Randomized Controlled ◽

First Line Treatment

Download Full-text

Efficacy and safety of PD‐1/PD‐L1 inhibitor plus chemotherapy versus chemotherapy alone as first‐line treatment for extensive‐stage small cell lung cancer: A systematic review and meta‐analysis

Thoracic Cancer ◽

10.1111/1759-7714.13698 ◽

2020 ◽

Vol 11 (12) ◽

pp. 3536-3546

Author(s):

Shuang Zhang ◽

Shuang Li ◽

Ying Cheng

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Meta Analysis ◽

Small Cell ◽

Line Treatment ◽

Efficacy And Safety ◽

Small Cell Lung ◽

First Line ◽

Extensive Stage ◽

First Line Treatment

Download Full-text

A multi-center, randomized, double-blind, parallel, two-group phase III clinical study on the efficacy and safety of QL1101 or bevacizumab in combination with paclitaxel and carboplatin in the first-line treatment of non-squamous non-small cell lung cancer

Annals of Oncology ◽

10.1093/annonc/mdz063.070 ◽

2019 ◽

Vol 30 ◽

pp. ii62

Author(s):

B. Han ◽

K. Li ◽

T. Chu ◽

M. Bi ◽

H. Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Study ◽

Small Cell ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

Small Cell Lung ◽

First Line ◽

Double Blind ◽

First Line Treatment

Download Full-text